Vargas A, Mateo A, Bello Z, Rodriguez Y, Lemos D, Duron Andino R
Rev Panam Salud Publica. 2024; 48:e125.
PMID: 39687246
PMC: 11648034.
DOI: 10.26633/RPSP.2024.125.
da Silva T, Moreira C, Souza J, Fernandes E, Gurmao J, de Melo Araujo A
PLoS One. 2024; 19(12):e0311932.
PMID: 39637119
PMC: 11620702.
DOI: 10.1371/journal.pone.0311932.
Tsai Y, Leung J, Anderson T, Zhou F, Singleton J
Vaccine. 2024; 43(Pt 1):126537.
PMID: 39579649
PMC: 11878214.
DOI: 10.1016/j.vaccine.2024.126537.
Nascimento L, de Melo Araujo A, de Souza P, Matozinhos F, da Silva T, Fernandes E
Rev Panam Salud Publica. 2024; 48:e31.
PMID: 38686133
PMC: 11053370.
DOI: 10.26633/RPSP.2024.31.
Ateudjieu J, Tchio-Nighie K, Yakum M, Goura A, Amada L, Sonkoua I
J Public Health Afr. 2023; 14(9):2450.
PMID: 37937064
PMC: 10626340.
DOI: 10.4081/jphia.2023.2450.
How well do coverage surveys and programmatically reported mass drug administration coverage match? Results from 214 mass drug administration campaigns in 15 countries, 2008-2017.
Zoerhoff K, Mbabazi P, Gass K, Kraemer J, Fuller B, Blair L
BMJ Glob Health. 2023; 8(5).
PMID: 37142297
PMC: 10163531.
DOI: 10.1136/bmjgh-2022-011193.
Methodological changes implemented over time to support accurate and timely COVID-19 vaccine coverage estimates: Ontario, Canada.
Hobbs J, Paul L, Buchan S, Harris T, Wilson S
Vaccine. 2023; 41(21):3328-3336.
PMID: 37087395
PMC: 10080273.
DOI: 10.1016/j.vaccine.2023.04.007.
Vaccination coverage estimation in Mexico in children under five years old: Trends and associated factors.
Rios-Blancas M, Lamadrid-Figueroa H, Betancourt-Cravioto M, Lozano R
PLoS One. 2021; 16(4):e0250172.
PMID: 33861792
PMC: 8051786.
DOI: 10.1371/journal.pone.0250172.
Pairs of independent nationally representative vaccination coverage surveys conducted within one year of each other: A global overview covering 2000-2019.
Brown D, Danovaro-Holliday M, Rhoda D
Vaccine X. 2021; 7:100085.
PMID: 33644743
PMC: 7887424.
DOI: 10.1016/j.jvacx.2021.100085.
Implementing WHO guidance on conducting and analysing vaccination coverage cluster surveys: Two examples from Nigeria.
Wagai J, Rhoda D, Prier M, Trimmer M, Clary C, Oteri J
PLoS One. 2021; 16(2):e0247415.
PMID: 33635913
PMC: 7909665.
DOI: 10.1371/journal.pone.0247415.
Evolution of the monitoring and evaluation strategies to support the World Health Organization's Global Programme to Eliminate Lymphatic Filariasis.
Lammie P, Gass K, King J, Deming M, Addiss D, Biswas G
Int Health. 2020; 13(Suppl 1):S65-S70.
PMID: 33349883
PMC: 7753166.
DOI: 10.1093/inthealth/ihaa084.
A Multicountry Comparison of Three Coverage Evaluation Survey Sampling Methodologies for Neglected Tropical Diseases.
Gass K, Deming M, Bougma R, Drabo F, Tukahebwa E, Mkwanda S
Am J Trop Med Hyg. 2020; 103(4):1700-1710.
PMID: 32840202
PMC: 7543869.
DOI: 10.4269/ajtmh.19-0946.
Are census data accurate for estimating coverage of a lymphatic filariasis MDA campaign? Results of a survey in Sierra Leone.
Kamara W, Zoerhoff K, Toubali E, Hodges M, Bisanzio D, Chowdhury D
PLoS One. 2019; 14(12):e0224422.
PMID: 31856176
PMC: 6922463.
DOI: 10.1371/journal.pone.0224422.
Using models to shape measles control and elimination strategies in low- and middle-income countries: A review of recent applications.
Cutts F, Dansereau E, Ferrari M, Hanson M, McCarthy K, Metcalf C
Vaccine. 2019; 38(5):979-992.
PMID: 31787412
PMC: 6996156.
DOI: 10.1016/j.vaccine.2019.11.020.
[Experience with development of tools to monitor vaccination coverage and preventive chemotherapy coverageExperiência do desenvolvimento de ferramentas para o monitoramento da cobertura vacinal e quimioprofilaxia].
Saboya-Diaz M, Morice A, Danovaro-Holliday M, Ruiz Matus C, Castellanos L, Velandia-Gonzaez M
Rev Panam Salud Publica. 2019; 41.
PMID: 31385958
PMC: 6645284.
DOI: 10.26633/RPSP.2017.141.
Measles and rubella serosurvey identifies rubella immunity gap in young adults of childbearing age in Zambia: The added value of nesting a serological survey within a post-campaign coverage evaluation survey.
Hayford K, Mutembo S, Carcelen A, Matakala H, Munachoonga P, Winter A
Vaccine. 2019; 37(17):2387-2393.
PMID: 30905529
PMC: 6467544.
DOI: 10.1016/j.vaccine.2019.02.037.
Coverage and timeliness of vaccination and the validity of routine estimates: Insights from a vaccine registry in Kenya.
Adetifa I, Karia B, Mutuku A, Bwanaali T, Makumi A, Wafula J
Vaccine. 2018; 36(52):7965-7974.
PMID: 30416017
PMC: 6288063.
DOI: 10.1016/j.vaccine.2018.11.005.
Improving immunization data quality in Peru and Mexico: Two case studies highlighting challenges and lessons learned.
Trumbo S, Contreras M, Garcia A, Diaz F, Gomez M, Carrion V
Vaccine. 2018; 36(50):7674-7681.
PMID: 30414780
PMC: 6263272.
DOI: 10.1016/j.vaccine.2018.10.083.
Improving measles incidence inference using age-structured serological data.
Prada J, Metcalf C, Ferrari M
Epidemiol Infect. 2018; 146(13):1699-1706.
PMID: 30078387
PMC: 9507956.
DOI: 10.1017/S0950268818002054.
Reply to comments on Monitoring vaccination coverage: Defining the role of surveys.
Cutts F, Claquin P, Danovaro-Holliday M, Rhoda D
Vaccine. 2016; 34(50):6112-6113.
PMID: 27899197
PMC: 5142421.
DOI: 10.1016/j.vaccine.2016.09.067.
